Measles elimination in Italy: Data from laboratory activity, 2011-2013

Journal of Clinical Virology

Volumn 64, Issue , 2015, Pages 34-39

  Magurano, Fabio ^a   Baggieri, Melissa ^a   Fortuna, Claudia ^a   Bella, Antonino ^a   Filia, Antonietta ^a   Rota, Maria Cristina ^a   Benedetti, Eleonora ^a   Bucci, Paola ^a   Marchi, Antonella ^a   Nicoletti, Loredana ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Laboratory diagnosis; Laboratory surveillance; Measles; Measles elimination

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY; MEASLES ANTIBODY; MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE; IMMUNOGLOBULIN M; VIRUS ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; BLOOD EXAMINATION; CEREBROSPINAL FLUID EXAMINATION; CHILD; DISEASE ELIMINATION; DISEASE SURVEILLANCE; DRIED BLOOD SPOT TESTING; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INFANT; ITALY; MAJOR CLINICAL STUDY; MEASLES; MEASLES VACCINATION; PHYLOGENY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROLOGY; URINALYSIS; VIRUS TRANSMISSION; BLOOD; DISEASE ERADICATION; DNA SEQUENCE; EUROPE; GENETICS; GENOTYPE; HEALTH SURVEY; IMMUNOLOGY; ISOLATION AND PURIFICATION; LABORATORY; MEASLES VIRUS; TIME; URINE;

ANTIBODIES, VIRAL; DISEASE ERADICATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EUROPE; GENOTYPE; HUMANS; IMMUNOGLOBULIN M; ITALY; LABORATORIES; MEASLES; MEASLES VIRUS; PHYLOGENY; PUBLIC HEALTH SURVEILLANCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; TIME FACTORS;

EID: 84923365986     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2014.12.019     Document Type: Article

References (29)

1. World Health Organization (WHO). Renewed commitment to measles and rubella elimination and prevention of congenital rubella syndrome in the WHO European Region by 2015. Regional Committee for Europe. Sixtieth session. Moscow, 13-16 September 2010. http://www.euro.who.int/__data/assets/pdf_file/0008/119546/RC60_edoc15pdf.
2. World Health Organization Progress in reducing global measles deaths: global measles and rubella laboratory network-update. Wkly. Epidemiol. Rec. 2006, 81:90-94.
3. CDC 2004. Progress in reducing measles mortality-worldwide, 1999-2003, MMWR, 2005; 54: 200-203.
4. Papania M.J., Orenstein W.A. Defining and assessing measles elimination goals. J. Infect. Dis. 2004, 189(Suppl. 1):S23-S26.
5. Parent du Châtelet I., Antona D., Freymuth F., Muscat M., Halftermeyer-Zhou F., Maine C., et al. Spotlight on measles 2010: update on the ongoing measles outbreak in France, 2008-2010. Euro Surveillance 1965, pii=19656.
6. Kremer J.R., Brown K.E., Jin L., Santibanez S., Shulga S.V., et al. High genetic diversity of measles virus. World Health Organization, European region, 2005-2006. Emerg. Infect. Dis. 2008, 14:107-114.
7. Italian Ministry of Health. Piano Nazionale per l'Eliminazione del Morbillo e della Rosolia congenita (PNEMoRc). Rome: Ministero della Salute. Italian. Available from:. http://www.salute.gov.it/imgs/C_17_pubblicazioni_1519_allegato.pdf.
8. Italian Ministry of Health. Malattie infettive e vaccinazioni. Coperture vaccinali. [Infectious diseases and vaccinations. Vaccine coverage]. Rome: Ministero della Salute. [Accessed 2 October 2013]. Italian. Available from:. http://www.salute.gov.it/imgs/C_17_pagineAree_811_listaFile_itemName_16_file.pdf.
9. Filia A., Bella A., Rota M.C., Tavilla A., Magurano F., Baggieri M., Nicoletti L., Iannazzo S., Pompa M.G., Declich S. Analysis of national measles surveillance data in Italy from October 2010 to December 2011 and priorities for reaching the 2015 measles elimination goal. Euro Surveillance 2013, 18(20):1-7. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20480.
10. WHO. Surveillance Guidelines for Measles, Rubella and Congenital Rubella Syndrome in the WHO European Region Update December 2012. Available from:. http://www.euro.who.int/__data/assets/pdf_file/0018/79020/e93035-2013%20pdf%3Fua=1.
11. Italia Circolare del Ministero della Salute DGPRE n. 4460-P-20/02/2013. Istituzione di un sistema di sorveglianza integrato per il morbillo e la rosolia alla luce del nuovo Piano Nazionale di Eliminazione del morbillo e della rosolia congenita 2010-2015.
12. Measles Rubella Laboratory Data Management System, (MR LDMS) Copenhagen, WHO Regional Office for Europe. Available at: mrldms.euro.who.int (last accessed 19 November 2013.
13. World Health Organization Regional Office for Europe. WHO Epidemiological brief. Copenhagen; 2012;21:5-9. Available from:. http://www.euro.who.int/en/what-we-do/health-topics/disease-prevention/vaccines-and-immunization/publications/2012/vpd-data-summary-table-january-december-2011-as-of-1-march-2012.
14. World Health Organization Regional Office for Europe. WHO EpiBrief, 2013, 1:1-4. Available from:. http://www.euro.who.int/__data/assets/pdf_file/0011/187571/EpiBrief-Issue-1,-2013-final.pdf%3Fua=1.
15. World Health Organization Regional Office for Europe. WHO EpiBrief, 2014, 2:1-9. http://www.euro.who.int/__data/assets/pdf_file/0020/254234/EpiBrief_2_2014-rev3-with-data.pdf%3Fua=1.
16. ECDC surveillance report 2013. Annual epidemiological report. Reporting on 2011 surveillance data and 2012 epidemic intelligence data. Available at:. http://www.ecdc.europa.eu.
17. European Commission. Commission Decision of 28 April 2008 (2008/426/EC) amending Decision 2002/253/EC laying down case definitions for reporting communicable diseases to the Community network under Decision No 2119/98/EC of the European Parliament and of the Council. Official Journal of the European Union 18/6/2008; L159/46. Available from:. http://www.euro.who.int/__data/assets/pdf_file/0020/215480/PACKAGE-FOR-ACCELERATED-ACTION-20132015.%20pdf.
18. Holm-Hansen C., Tong G., Davis C., Abrams W.R., Malamud D. Comparison of oral fluid collectors for use in a rapid point-of-care diagnostic device. Clin. Diagn. Lab. Immunol. 2004, 11(September (5)):909-912.
19. Novello F., Ridolfi B., Fiore L., Buttinelli G., Medda E., Favero A., Marchetti D., Gaglioppa F. Comparison of capillary blood versus venous blood samples in the assessment of immunity to measles. J. Virol. Meth. 1996, 61(1-2):73-77.
20. WHO Expanded Programme on Immunization. Manual for the laboratory diagnosis of measles and rubella virus infection, 2nd ed. Geneva, World Health Organization. 2007. Available from:. http://www.who.int/ihr/elibrary/manual_diagn_lab_mea_rub_en.pdf.
21. Chibo D., Birch C.J., Rota P.A., Catton M.G. Molecular characterization of measles viruses isolated in Victoria, Australia, between 1973 and 1998. J. Gen. Virol. 2000, 81(Pt 10):2511-2518.
22. Hübschen J.M., Kremer J.R., De Landtsheer S., Muller C.P. A multiplex TaqMan PCR assay for the detection of measles and rubella virus. J. Virol. Meth. 2008, 149(2):246-250.
23. Tamura K., Stecher G., Peterson D., Filipski A., Kumar S. MEGA6: molecular evolutionary genetics analysis version 6.0. Mol. Biol. Evol. 2013, 30:2725-2729.
24. WHO Expanded programme on immunization±standardization of the nomenclature for describing the genetic characteristics of wild-type measles viruses. Week Epidemiol. Rep. 1998, 73:265-269.
25. World Health Organization Measles virus nomenclature, update 2012. Wkly Epidemiol Rec. 87 2012 73-80. http://www.who.int/wer.
26. Muscat M., Shefer A., Ben Mamou M., Spataru R., Jankovic D., Deshevoy S., Butler R., Pfeifer D. The state of measles and rubella in the WHO European Region, 2013. Clin. Microbiol. Infect. 2014, 20:12-18.
27. Jin L., Vyse A., Brown D.W.G. The role of RT-PCR assay of oral fluid for diagnosis and surveillance of measles, mumps and rubella. Bull. World Health Org. 2002, 80(1).
28. Muscat M. Who gets measles in Europe. J. Infect. Dis. 2011, 204(Suppl. 1):S353-S365.
29. World Health Organization Regional Office for Europe. Measles and Rubella Elimination 2015-Package for Accelerated Action: 2013-2015. Copenhagen: WHO Regional Office for Europe. Available at: (last accessed 29 January 2014. http://www.euro.who.int/__data/assets/pdf_file/0020/215480/PACKAGE-FOR-ACCELERATED-ACTION-20132015.%20pdf.